The Protein Engineering Market size was estimated USD 2.2 billion in 2022 and is expected to reach USD 7.5 billion by 2030 at a CAGR of 16.7% during the forecast period of 2023-2030.
Protein engineering is the process of modifying protein structures in order to synthesize proteins with specific structures or desired properties. The procedure is characterized as the creation of new proteins with desired features. The technique is widely employed in a variety of industries, including manufacturing, research, biotechnology, medicine, and health care, among others.
.png)
Get more information on Protein Engineering Market - Request Free Sample Report
DRIVERS
Protein-based medicines and therapies are becoming increasingly popular.
The increasing demand for protein-based pharmaceuticals is critical for the protein engineering market. Biologics, or protein-based medications, are increasingly being used to treat a variety of ailments, including cancer, autoimmune disorders, and uncommon genetic abnormalities. Protein-based therapeutics have significant advantages over typical small-molecule medications. Because they are designed to interact with specific targets in the body, they are often more selective and have fewer side effects.
RESTRAIN
Development is expensive
Protein engineering is a time-consuming and difficult process of designing, manufacturing, and testing proteins with specified features. This process necessitates significant expenditure in R&D, creating a significant barrier to entry for smaller businesses and startups. In addition to the direct expenses of research and development, the indirect costs of bringing protein-based products to market.
OPPORTUNITY
Gene editing and synthetic biology advancements
Researchers can change and reprogram the genetic code of cells using gene editing and synthetic biology technologies, which can result in the development of novel proteins with unique features. Using CRISPR/Cas9 gene editing technologies to change genes that code for specific proteins is one potential field of research. Synthetic biology also offers new opportunities for protein engineering. Synthetic biology involves designing and constructing new biological systems using DNA and other biological components. Researchers use synthetic biology techniques to create or modify existing proteins to perform specific functions.
CHALLENGES
High production costs of therapeutic proteins
Dearth of skilled professionals
Amgen, Inc. experienced changes in demand for some of their medicines throughout the pandemic as fluctuations in the frequency of patient visits to doctors' offices impacted the provision of therapies to existing patients and reduced diagnosis in new patients. The pandemic continued to have an impact on the healthcare industry and company business in 2022, to varied degrees throughout markets. With the exception of the Asia Pacific region, which was hit by lockdowns for the majority of the year, improved stability in patient visits and demand patterns were observed in 2022, even in places experiencing virus surges. Given COVID-19's evolution since its inception, including the proliferation of variations, the company cannot forecast the impact of future virus surges on business and will continue to closely monitor the impact of COVID-19 on business and the healthcare industry more broadly.
By Product
Instruments
Reagents
Software & Services
In 2022, Instruments segment is expected to held the highest market share of 51.6% during the forecast period due to the researchers are increasingly selecting automated technologies to promote speedy molecular development procedures, which is one of the key reasons driving segment expansion. Furthermore, increased demand for high-efficiency protein engineering tools, such as real-time PCR apparatus and chromatographic systems, is expected to drive segment growth throughout the projection period.
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
In 2022, rational protein design segment is expected to held the highest market share of 30.0% during the forecast period due to the widespread use of this technology in protein engineering and antibody creation. The rapid increase of commercial applications of enzyme engineering has resulted in the production of enhanced and modified enzymes with the appropriate catalytic characteristics. Techniques such as site-directed mutagenesis are commonly utilized in rational design engineering approaches, and the significant market penetration of such techniques contributes in driving the category.
By Protein Type
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
In 2022, the monoclonal antibodies segment is expected to dominate the market growth of 23.2% during the forecast period due to increasing R&D spending on the development of therapeutically improved monoclonal antibodies is one of the key drivers driving the expanding use of these technologies. Furthermore, the growing use of targeted monoclonal antibodies for the treatment of cancer and other chronic diseases is projected to drive growth in the market during the forecast period. Similarly, the emergence of genetic platforms that leverage cutting-edge technology, such as next-generation sequencing, to enable efficient protein engineering for the synthesis of monoclonal antibodies, is predicted to boost growth potential even more.
By End User
Academic Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
.png)
Need any customization research on Protein Engineering Market - Enquiry Now
In 2022, pharmaceutical & biotechnology companies segment is expected to dominate the market growth of 42.6% during the forecast period due to the expanding usage of in silico drug development models for the treatment of diabetes, cancer, and neurological diseases is responsible for the substantial proportion. These businesses are always working to preserve their market position by producing drug versions of patent-expiring pharmaceuticals utilizing a computer modeling technique. Furthermore, the segment is being fueled by increased funding and financial support from public and commercial healthcare organizations for the development of sophisticated protein engineering technologies to improve patient outcomes.
North America held a significant market share growing with a highest CAGR of 41.2% in 2022 due to growing number of collaborations promoted by leading market participants to increase their R&D skills are expected to be responsible for this region's larger share. For example, in September 2021, Selecta Biosciences, Inc. and Cyrus Biotechnology, Inc. announced a protein engineering collaboration that paired Selecta's ImmTOR platform with Cyrus' ability to fundamentally restructure protein therapeutics. The major goal of the partnership was to create an exclusive interleukin-2 (IL-2) agonist designed to specifically boost regulatory T cell (Treg) proliferation for the treatment of autoimmune diseases.
Asia-Pacific is witness to expand fastest CAGR rate during the forecast period due to the high prevalence of cancer, cardiovascular disease, and autoimmune illnesses in developing Asian countries. Furthermore, undiscovered potential in this region are likely to contribute to the sector's growth due to the rapid economic development of emerging economies such as India and China. Furthermore, the presence of a large population base for the research and clinical testing of protein engineering applications is expected to accelerate the region's growth.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are Agilent Technologies, Bruker Cor., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corp., Insightful Science, Bio-Rad Laboratories, Merck KGaA, Danaher Corp., Genscript Biotech Corp., Amgen, Inc., and Others.
In Jan 2022, Amgen and Generate Biomedicines have signed a research partnership agreement to find and develop protein therapies for five clinical targets spanning several therapeutic areas and modes of delivery.
In December 2021, Insightful Science, a cloud-based software company that enables scientific discovery, announced the completion of its acquisition of Protein Metrics, Inc., a leading provider of biopharmaceutical protein characterization and proteomics analysis software. The acquisition broadens the Company's R&D value chain, broadening the biopharmaceutical protein analysis arena and removing data analysis constraints associated with large-scale protein research.
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.2 Billion |
| Market Size by 2030 | US$ 7.5 Billion |
| CAGR | CAGR of 16.7 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Instruments, Reagents, Software & Services) • By Technology (Rational Protein Design, Directed Evolution, Hybrid Approach, De Novo Protein Design, Others) • By Protein Type (Insulin, Monoclonal Antibodies, Vaccines, Growth Factors, Colony Stimulating Factors, Coagulation Factors, Interferon, Others) • By End User (Academic Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Agilent Technologies, Bruker Cor., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corp., Insightful Science, Bio-Rad Laboratories, Merck KGaA, Danaher Corp., Genscript Biotech Corp., Amgen, Inc. |
| Key Drivers | • Protein-based medicines and therapies are becoming increasingly popular. |
| Market Opportunity | • Gene editing and synthetic biology advancements |
Ans: Protein Engineering Market size was valued at USD 2.2 billion in 2022.
Ans: The Protein Engineering Market is expected to grow at 16.7% CAGR from 2023 to 2030.
Ans: According to our analysis, the Protein Engineering Market is anticipated to reach USD 7.5 billion by 2030.
Ans: Protein-based medicines and therapies are becoming increasingly popular.
Ans: Yes, you may request customization based on your company's needs.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Protein Engineering Market Segmentation, by Product
8.1Instruments
8.2Reagents
8.3Software & Services
9. Protein Engineering Market Segmentation, by Technology
9.1Rational Protein Design
9.2Directed Evolution
9.3Hybrid Approach
9.4De Novo Protein Design
9.5Others
10. Protein Engineering Market Segmentation, by Protein Type
10.1 Insulin
10.2 Monoclonal Antibodies
10.3 Vaccines
10.4 Growth Factors
10.5 Colony Stimulating Factors
10.6 Coagulation Factors
10.7 Interferon
10.8 Others
11. Protein Engineering Market Segmentation, by End User
11.1 Academic Research Institutes
11.2 Contract Research Organizations
11.3 Pharmaceutical & Biotechnology Companies
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Protein Engineering Market by Country
12.2.2 North America Protein Engineering Market by Product
12.2.3 North America Protein Engineering Market by Technology
12.2.4 North America Protein Engineering Market by Protein Type
12.2.5 North America Protein Engineering Market by End User
12.2.6 USA
12.2.6.1 USA Protein Engineering Market by Product
12.2.6.2 USA Protein Engineering Market by Technology
12.2.6.3 USA Protein Engineering Market by Protein Type
12.2.6.4 USA Protein Engineering Market by End User
12.2.7 Canada
12.2.7.1 Canada Protein Engineering Market by Product
12.2.7.2 Canada Protein Engineering Market by Technology
12.2.7.3 Canada Protein Engineering Market by Protein Type
12.2.7.4 Canada Protein Engineering Market by End User
12.2.8 Mexico
12.2.8.1 Mexico Protein Engineering Market by Product
12.2.8.2 Mexico Protein Engineering Market by Technology
12.2.8.3 Mexico Protein Engineering Market by Protein Type
12.2.8.4 Mexico Protein Engineering Market by End User
12.3 Europe
12.3.1 Eastern Europe
12.3.1.1 Eastern Europe Protein Engineering Market by Country
12.3.1.2 Eastern Europe Protein Engineering Market by Product
12.3.1.3 Eastern Europe Protein Engineering Market by Technology
12.3.1.4 Eastern Europe Protein Engineering Market by Protein Type
12.3.1.5 Eastern Europe Protein Engineering Market by End User
12.3.1.6 Poland
12.3.1.6.1 Poland Protein Engineering Market by Product
12.3.1.6.2 Poland Protein Engineering Market by Technology
12.3.1.6.3 Poland Protein Engineering Market by Protein Type
12.3.1.6.4 Poland Protein Engineering Market by End User
12.3.1.7 Romania
12.3.1.7.1 Romania Protein Engineering Market by Product
12.3.1.7.2 Romania Protein Engineering Market by Technology
12.3.1.7.3 Romania Protein Engineering Market by Protein Type
12.3.1.7.4 Romania Protein Engineering Market by End User
12.3.1.8 Hungary
12.3.1.8.1 Hungary Protein Engineering Market by Product
12.3.1.8.2 Hungary Protein Engineering Market by Technology
12.3.1.8.3 Hungary Protein Engineering Market by Protein Type
12.3.1.8.4 Hungary Protein Engineering Market by End User
12.3.1.9 Turkey
12.3.1.9.1 Turkey Protein Engineering Market by Product
12.3.1.9.2 Turkey Protein Engineering Market by Technology
12.3.1.9.3 Turkey Protein Engineering Market by Protein Type
12.3.1.9.4 Turkey Protein Engineering Market by End User
12.3.1.10 Rest of Eastern Europe
12.3.1.10.1 Rest of Eastern Europe Protein Engineering Market by Product
12.3.1.10.2 Rest of Eastern Europe Protein Engineering Market by Technology
12.3.1.10.3 Rest of Eastern Europe Protein Engineering Market by Protein Type
12.3.1.10.4 Rest of Eastern Europe Protein Engineering Market by End User
12.3.2 Western Europe
12.3.2.1 Western Europe Protein Engineering Market by Country
12.3.2.2 Western Europe Protein Engineering Market by Product
12.3.2.3 Western Europe Protein Engineering Market by Technology
12.3.2.4 Western Europe Protein Engineering Market by Protein Type
12.3.2.5 Western Europe Protein Engineering Market by End User
12.3.2.6 Germany
12.3.2.6.1 Germany Protein Engineering Market by Product
12.3.2.6.2 Germany Protein Engineering Market by Technology
12.3.2.6.3 Germany Protein Engineering Market by Protein Type
12.3.2.6.4 Germany Protein Engineering Market by End User
12.3.2.7 France
12.3.2.7.1 France Protein Engineering Market by Product
12.3.2.7.2 France Protein Engineering Market by Technology
12.3.2.7.3 France Protein Engineering Market by Protein Type
12.3.2.7.4 France Protein Engineering Market by End User
12.3.2.8 UK
12.3.2.8.1 UK Protein Engineering Market by Product
12.3.2.8.2 UK Protein Engineering Market by Technology
12.3.2.8.3 UK Protein Engineering Market by Protein Type
12.3.2.8.4 UK Protein Engineering Market by End User
12.3.2.9 Italy
12.3.2.9.1 Italy Protein Engineering Market by Product
12.3.2.9.2 Italy Protein Engineering Market by Technology
12.3.2.9.3 Italy Protein Engineering Market by Protein Type
12.3.2.9.4 Italy Protein Engineering Market by End User
12.3.2.10 Spain
12.3.2.10.1 Spain Protein Engineering Market by Product
12.3.2.10.2 Spain Protein Engineering Market by Technology
12.3.2.10.3 Spain Protein Engineering Market by Protein Type
12.3.2.10.4 Spain Protein Engineering Market by End User
12.3.2.11 Netherlands
12.3.2.11.1 Netherlands Protein Engineering Market by Product
12.3.2.11.2 Netherlands Protein Engineering Market by Technology
12.3.2.11.3 Netherlands Protein Engineering Market by Protein Type
12.3.2.11.4 Netherlands Protein Engineering Market by End User
12.3.2.12 Switzerland
12.3.2.12.1 Switzerland Protein Engineering Market by Product
12.3.2.12.2 Switzerland Protein Engineering Market by Technology
12.3.2.12.3 Switzerland Protein Engineering Market by Protein Type
12.3.2.12.4 Switzerland Protein Engineering Market by End User
12.3.2.13 Austria
12.3.2.13.1 Austria Protein Engineering Market by Product
12.3.2.13.2 Austria Protein Engineering Market by Technology
12.3.2.13.3 Austria Protein Engineering Market by Protein Type
12.3.2.13.4 Austria Protein Engineering Market by End User
12.3.2.14 Rest of Western Europe
12.3.2.14.1 Rest of Western Europe Protein Engineering Market by Product
12.3.2.14.2 Rest of Western Europe Protein Engineering Market by Technology
12.3.2.14.3 Rest of Western Europe Protein Engineering Market by Protein Type
12.3.2.14.4 Rest of Western Europe Protein Engineering Market by End User
12.4 Asia-Pacific
12.4.1 Asia Pacific Protein Engineering Market by Country
12.4.2 Asia Pacific Protein Engineering Market by Product
12.4.3 Asia Pacific Protein Engineering Market by Technology
12.4.4 Asia Pacific Protein Engineering Market by Protein Type
12.4.5 Asia Pacific Protein Engineering Market by End User
12.4.6 China
12.4.6.1 China Protein Engineering Market by Product
12.4.6.2 China Protein Engineering Market by Technology
12.4.6.3 China Protein Engineering Market by Protein Type
12.4.6.4 China Protein Engineering Market by End User
12.4.7 India
12.4.7.1 India Protein Engineering Market by Product
12.4.7.2 India Protein Engineering Market by Technology
12.4.7.3 India Protein Engineering Market by Protein Type
12.4.7.4 India Protein Engineering Market by End User
12.4.8 Japan
12.4.8.1 Japan Protein Engineering Market by Product
12.4.8.2 Japan Protein Engineering Market by Technology
12.4.8.3 Japan Protein Engineering Market by Protein Type
12.4.8.4 Japan Protein Engineering Market by End User
12.4.9 South Korea
12.4.9.1 South Korea Protein Engineering Market by Product
12.4.9.2 South Korea Protein Engineering Market by Technology
12.4.9.3 South Korea Protein Engineering Market by Protein Type
12.4.9.4 South Korea Protein Engineering Market by End User
12.4.10 Vietnam
12.4.10.1 Vietnam Protein Engineering Market by Product
12.4.10.2 Vietnam Protein Engineering Market by Technology
12.4.10.3 Vietnam Protein Engineering Market by Protein Type
12.4.10.4 Vietnam Protein Engineering Market by End User
12.4.11 Singapore
12.4.11.1 Singapore Protein Engineering Market by Product
12.4.11.2 Singapore Protein Engineering Market by Technology
12.4.11.3 Singapore Protein Engineering Market by Protein Type
12.4.11.4 Singapore Protein Engineering Market by End User
12.4.12 Australia
12.4.12.1 Australia Protein Engineering Market by Product
12.4.12.2 Australia Protein Engineering Market by Technology
12.4.12.3 Australia Protein Engineering Market by Protein Type
12.4.12.4 Australia Protein Engineering Market by End User
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific Protein Engineering Market by Product
12.4.13.2 Rest of Asia-Pacific Protein Engineering Market by Technology
12.4.13.3 Rest of Asia-Pacific Protein Engineering Market by Protein Type
12.4.13.4 Rest of Asia-Pacific Protein Engineering Market by End User
12.5 Middle East & Africa
12.5.1 Middle East
12.5.1.1 Middle East Protein Engineering Market by country
12.5.1.2 Middle East Protein Engineering Market by Product
12.5.1.3 Middle East Protein Engineering Market by Technology
12.5.1.4 Middle East Protein Engineering Market by Protein Type
12.5.1.5 Middle East Protein Engineering Market by End User
12.5.1.6 UAE
12.5.1.6.1 UAE Protein Engineering Market by Product
12.5.1.6.2 UAE Protein Engineering Market by Technology
12.5.1.6.3 UAE Protein Engineering Market by Protein Type
12.5.1.6.4 UAE Protein Engineering Market by End User
12.5.1.7 Egypt
12.5.1.7.1 Egypt Protein Engineering Market by Product
12.5.1.7.2 Egypt Protein Engineering Market by Technology
12.5.1.7.3 Egypt Protein Engineering Market by Protein Type
12.5.1.7.4 Egypt Protein Engineering Market by End User
12.5.1.8 Saudi Arabia
12.5.1.8.1 Saudi Arabia Protein Engineering Market by Product
12.5.1.8.2 Saudi Arabia Protein Engineering Market by Technology
12.5.1.8.3 Saudi Arabia Protein Engineering Market by Protein Type
12.5.1.8.4 Saudi Arabia Protein Engineering Market by End User
12.5.1.9 Qatar
12.5.1.9.1 Qatar Protein Engineering Market by Product
12.5.1.9.2 Qatar Protein Engineering Market by Technology
12.5.1.9.3 Qatar Protein Engineering Market by Protein Type
12.5.1.9.4 Qatar Protein Engineering Market by End User
12.5.1.10 Rest of Middle East
12.5.1.10.1 Rest of Middle East Protein Engineering Market by Product
12.5.1.10.2 Rest of Middle East Protein Engineering Market by Technology
12.5.1.10.3 Rest of Middle East Protein Engineering Market by Protein Type
12.5.1.10.4 Rest of Middle East Protein Engineering Market by End User
12.5.2. Africa
12.5.2.1 Africa Protein Engineering Market by country
12.5.2.2 Africa Protein Engineering Market by Product
12.5.2.3 Africa Protein Engineering Market by Technology
12.5.2.4 Africa Protein Engineering Market by Protein Type
12.5.2.5 Africa Protein Engineering Market by End User
12.5.2.6 Nigeria
12.5.2.6.1 Nigeria Protein Engineering Market by Product
12.5.2.6.2 Nigeria Protein Engineering Market by Technology
12.5.2.6.3 Nigeria Protein Engineering Market by Protein Type
12.5.2.6.4 Nigeria Protein Engineering Market by End User
12.5.2.7 South Africa
12.5.2.7.1 South Africa Protein Engineering Market by Product
12.5.2.7.2 South Africa Protein Engineering Market by Technology
12.5.2.7.3 South Africa Protein Engineering Market by Protein Type
12.5.2.7.4 South Africa Protein Engineering Market by End User
12.5.2.8 Rest of Africa
12.5.2.8.1 Rest of Africa Protein Engineering Market by Product
12.5.2.8.2 Rest of Africa Protein Engineering Market by Technology
12.5.2.8.3 Rest of Africa Protein Engineering Market by Protein Type
12.5.2.8.4 Rest of Africa Protein Engineering Market by End User
12.6. Latin America
12.6.1 Latin America Protein Engineering Market by country
12.6.2 Latin America Protein Engineering Market by Product
12.6.3 Latin America Protein Engineering Market by Technology
12.6.4 Latin America Protein Engineering Market by Protein Type
12.6.5 Latin America Protein Engineering Market by End User
12.6.6 Brazil
12.6.6.1 Brazil Protein Engineering Market by Product
12.6.6.2 Brazil Protein Engineering Market by Technology
12.6.6.3 Brazil Protein Engineering Market by Protein Type
12.6.6.4 Brazil Protein Engineering Market by End User
12.6.7 Argentina
12.6.7.1 Argentina Protein Engineering Market by Product
12.6.7.2 Argentina Protein Engineering Market by Technology
12.6.7.3 Argentina Protein Engineering Market by Protein Type
12.6.7.4 Argentina Protein Engineering Market by End User
12.6.8 Colombia
12.6.8.1 Colombia Protein Engineering Market by Product
12.6.8.2 Colombia Protein Engineering Market by Technology
12.6.8.3 Colombia Protein Engineering Market by Protein Type
12.6.8.4 Colombia Protein Engineering Market by End User
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America Protein Engineering Market by Product
12.6.9.2 Rest of Latin America Protein Engineering Market by Technology
12.6.9.3 Rest of Latin America Protein Engineering Market by Protein Type
12.6.9.4 Rest of Latin America Protein Engineering Market by End User
13. Company Profile
13.1 Agilent Technologies
13.1.1 Company Overview
13.1.2 Financials
13.1.3 Products/ Services Offered
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Bruker Cor.
13.2.1 Company Overview
13.2.2 Financials
13.2.3 Products/ Services Offered
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Thermo Fisher Scientific, Inc.
13.3.1 Company Overview
13.3.2 Financials
13.3.3 Products/ Services Offered
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 PerkinElmer, Inc.
13.4 Company Overview
13.4.2 Financials
13.4.3 Products/ Services Offered
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Waters Corp.
13.5.1 Company Overview
13.5.2 Financials
13.5.3 Products/ Services Offered
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Bio-Rad Laboratories
13.6.1 Company Overview
13.6.2 Financials
13.6.3 Products/ Services Offered
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Merck KGaA
13.7.1 Company Overview
13.7.2 Financials
13.7.3 Products/ Services Offered
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 Danaher Corp.
13.8.1 Company Overview
13.8.2 Financials
13.8.3 Products/ Services Offered
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Genscript Biotech Corp.
13.9.1 Company Overview
13.9.2 Financials
13.9.3 Products/ Services Offered
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Amgen, Inc.
13.10.1 Company Overview
13.10.2 Financials
13.10.3 Products/ Services Offered
13.10.4 SWOT Analysis
13.10.5 The SNS View
13.11 Insightful Science
13.11.1 Company Overview
13.11.2 Financials
13.11.3 Products/ Services Offered
13.11.4 SWOT Analysis
13.11.5 The SNS View
14. Competitive Landscape
14.1 Competitive Bench marking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions
15. USE Cases and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The 3D Printed Brain Model Market Size was valued at USD 32.82 million in 2022 and is expected to reach USD 109.11 million by 2030, and grow at a CAGR of 16.2% over the forecast period 2023-2030.
The Neurovascular Devices Market Size was valued at USD 2.81 billion in 2022, and is expected to reach USD 4.51 billion by 2030, and grow at a CAGR of 6.1% over the forecast period 2023-2030.
The Brain Tumor Drugs Market was estimated at US$ 2.9 billion in 2022 and is expected to reach US$ 5.73 billion by 2030. and is anticipated to increase at a CAGR of 8.9% predicted for the forecast period of 2022-2030.
The Biomaterials Market size was estimated USD 156.1 billion in 2022 and is expected to reach USD 501.2 billion by 2030 at a CAGR of 15.7% during the forecast period of 2023-2030.
The Cancer Diagnostics Market Size was valued at USD 114.6 billion in 2023 and is expected to reach USD 185.4 billion by 2031 and grow at a CAGR of 6.2% over the forecast period 2024-2031.
The Cardiology Information System (CIS) Market Size was valued at USD 1051.77 million in 2022, and is expected to reach USD 2158.03 million by 2030, and grow at a CAGR of 9.4% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
